4). Administration of alum

increases the number of eosinophils in the peritoneal cavity and in spleen 8, 16. Therefore, animals were injected with phOx-CSA/alum or with alum only, and the percentage and the total number of eosinophils in the BM were determined (Fig. 4A and B). Injection with alum alone induced an increase in the numbers of eosinophils, which was nearly as large as was achieved by immunization with adjuvant plus antigen. However, 3 weeks after administration of alum, the number of eosinophils had fallen to nearly baseline levels (Fig. 4C and D). Only in the presence of antigen was a stable increase in the percentage and number of eosinophils observed (Fig. 4A–D). After secondary challenge, an increase in the numbers of eosinophils was only seen Ibrutinib in animals that had been primed with both antigen and adjuvant, but not in those injected with alum alone (Fig. 4B–D). Thus, the induction of a T-cell-dependent immune response is accompanied by augmented numbers of eosinophils in the BM. To determine the capacity of eosinophils to support plasma cell survival in vitro, eosinophils were isolated from

BM aspirates. In vitro cultures of plasma cells and eosinophils were set up with eosinophils isolated from the BM of naïve animals or from BM of animals immunized with phOx-CSA/alum. Eosinophils were prepared 60 days after primary (late 1°) and 6 NVP-AUY922 solubility dmso days after secondary immunization (early 2°) (Fig. 5). After 48 h of co-culture with these eosinophil populations, the survival of plasma cells was determined by staining with Annexin-V and PI (Fig. 5A and B) and by ELISPOT (Fig. 5C). The data show that eosinophils prevented plasma cells from going into apoptosis. Eosinophils from early secondary immunized animals (6 days after boost

with soluble antigen) were more efficient at supporting plasma cell survival than were eosinophils from the BM ifoxetine of late primary (60 days after antigen priming) immunized animals. After 48 h of co-culture with eosinophils isolated from the BM of secondary immunized animals, about half of the plasma cells were still PI– Annexin-V– (Fig. 5B) and could be recovered as antibody secreting cells (Fig. 5C). These data demonstrate that upon immunization with the T-cell-dependent antigen phOx, eosinophils become activated and with activation they gain the capability to support plasma cell survival (Fig. 5). Recently, it was shown that eosinophils support the maintenance of plasma cells in the BM where eosinophils are the main source of the plasma cells survival factors APRIL and IL-6 9. As a consequence of immunization, eosinophils gain an activated phenotype and show increased levels of cytokine secretion. Here, we show that eosinophils are activated by the injection of adjuvant alone, but that a stable activation is only achieved in the presence of antigen as well.